Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1

Interventions

vandetanib 1pembrolizumab 1lenvatinib 1fosbretabulin 1fludarabine 1combretastatin 1aldesleukin 1Water 1Thyroxine 1Thyrotropin-Releasing Hormone 1Tea 1Paclitaxel 1Milk 1Iodine-124 1Iodine-123 1Fluorodeoxyglucose F18 1Drug Therapy 1Docetaxel 1DNA 1Cyclophosphamide 1Coffee 1Carboplatin 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Thyroid Neoplasms × Thyrotropin-Releasing Hormone × Clear all
NCT04868045 2023-02-21

Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Withdrawn
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡